Boston Scientific Hit by Cyberattack, Shares Fall 3.5% Premarket
Boston Scientific, a medical device maker with a market value of $72 billion, said it suffered a cyberattack this week that disrupted operations and shipments. The company is working to restore affected functions and system access, but the timeline for full recovery remains uncertain. Shares fell 3.5% in premarket trading.
Boston Scientific Corp. said it was hit by a cyberattack this week that disrupted its operations and shipments. The company, which makes medical devices such as pacemakers and stents, said it is working to restore affected functions and system access, but the timing of a full recovery remains uncertain.
The attack has affected the company's ability to ship products, though it did not specify the extent of the disruption. Boston Scientific, which has a market value of about $72 billion, saw its shares fall 3.5% in premarket trading.
The company said it is taking steps to mitigate the impact and is assessing the situation. It did not provide further details on the nature of the attack or when operations would return to normal.